Longitudinal analysis of verbal episodic memory in patients with relapsing-remitting multiple sclerosis

Longitudinal analysis of verbal episodic memory in patients with relapsing-remitting multiple sclerosis

ABSTRACT Objective: A 4.5-year follow-up study was conducted to characterize baseline verbal episodic memory (VEM) and its behavior and to assess the effects of relapsing-remitting multiple sclerosis (RRMS) on this domain. Methods: Twenty-nine patients with RRMS underwent two neuropsychological as...

Full description

Saved in:

Bibliographic Details
Main Authors:	Izadora Nogueira Fonte Boa, Carolina de Medeiros Rimkus, Kenia Repiso Campanholo, Samira Luisa Apóstolos Pereira, Thiago de Faria Junqueira, Melissa de Almeida Rodrigues Machado, Dagoberto Callegaro, Maria Concepción García Otaduy, Claudia da Costa Leite, Eliane Correa Miotto
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações
Series:	Arquivos de Neuro-Psiquiatria
Subjects:	multiple sclerosis cognition longitudinal studies
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000500302&lng=en&tlng=en
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cognitive and Functional Impairment in Stroke Survivors with Basilar Artery Occlusive Disease
by: Kenia Repiso Campanholo, et al.
Published: (2015-01-01)

Hopkins verbal learning test-revised and brief visuospatial memory test-revised: preliminary normative data for the Brazilian population
by: Eliane Correa Miotto, et al.
Published: (2012-12-01)

Working memory impairment in multiple sclerosis relapsing-remitting patients with episodic memory deficits Prejuízo de memória operacional em pacientes com esclerose múltipla recorrente-remitente com déficits de memória episódica
by: Simone Freitas Fuso, et al.
Published: (2010-04-01)

Assessing female sexual dysfunction in patients with relapsing-remitting multiple sclerosis
by: Elisa Matias Vieira de Melo, et al.
Published: (2025-04-01)

Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
by: V. M. Alifirova, et al.
Published: (2010-08-01)

Volumetric assessment of hypothalamus in relapsing–remitting multiple sclerosis
by: Sara Sameh AbdelRahman Abdallah, et al.
Published: (2025-07-01)

Cognitive profile of patients with relapsing remitting multiple sclerosis
by: VIVIAN M. ANDRADE, et al.
Published: (1999-09-01)

Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis
by: Fernando Rodríguez-Jorge, et al.
Published: (2024-12-01)

The condition of the cardiovascular system in patients with relapsing-remitting multiple sclerosis
by: O. A. Traktirskaya, et al.
Published: (2019-03-01)

Adherence to therapeutic recommendation in relapsing-remitting multiple sclerosis patients
by: Justyna Chojdak-Łukasiewicz, et al.
Published: (2025-06-01)

Cerebellar Information Processing in Relapsing-Remitting Multiple Sclerosis (RRMS)
by: E. Lesage, et al.
Published: (2010-01-01)

Circulating exosomes with unique lipid signature in relapsing remitting multiple sclerosis
by: Claudia Palazzo, et al.
Published: (2025-06-01)

Correlation of Cognition With Disability and Physical Performance in Patients With Relapsing-Remitting MS
by: Marko Luostarinen, et al.
Published: (2025-06-01)

Eosinophilic Gastroenteritis with a Relapsing and Remitting Course with Presence of Autoimmune Antibodies
by: Chathuranga Lakmal Fonseka, et al.
Published: (2020-01-01)

Fear of Relapse Scale: Spanish version and psychometric characteristics in a sample of patients with Relapsing-Remitting multiple sclerosis
by: Y. Broche-Pérez, et al.
Published: (2024-11-01)

Balance Rehabilitation Unit (BRU TM) posturography in relapsing-remitting multiple sclerosis
by: Natália Kessler, et al.
Published: (2011-06-01)

Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosis
by: Rocío Gómez-Ballesteros, et al.
Published: (2025-07-01)

Positive correlation between functional disability, excessive daytime sleepiness, and fatigue in relapsing-remitting multiple sclerosis
by: Douglas Martins Braga, et al.
Published: (2016-06-01)

Neuromyelitis optica spectrum disorders: a review with a focus on children and adolescents
by: Renata Barbosa Paolilo, et al.
Published: (2023-02-01)

Different cognitive profiles of Brazilian patients with relapsing-remitting and primary progressive multiple sclerosis
by: Dóra-Neide Rodrigues, et al.
Published: (2011-08-01)

Comparative Effects of Vitamin D Supplementation on Oxidative Stress in Relapsing–Remitting Multiple Sclerosis
by: Martyna Lis, et al.
Published: (2024-12-01)

Predictive Significance of Interleukins 17A and 33 in Risk of Relapsing–Remitting Multiple Sclerosis
by: Milad Abdul Salam Al-Naseri, et al.
Published: (2022-12-01)

Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
by: Làzaro Aurelio Vàzquez Gòmez, et al.
Published: (2022-10-01)

Impact of natalizumab on ambulatory improvement in secondary progressive and disabled relapsing-remitting multiple sclerosis.
by: Diego Cadavid, et al.
Published: (2013-01-01)

Could rituximab revolutionize multiple sclerosis treatment in Brazil? The missed opportunity for fewer relapses and lower costs
by: Guilherme Diogo Silva, et al.
Published: (2025-09-01)

AQP4-IgG NMOSD, MOGAD, and double-seronegative NMOSD: is it possible to depict the antibody subtype using magnetic resonance imaging?
by: Diego Cardoso Fragoso, et al.
Published: (2023-06-01)

The liminal space between hope and grief: The phenomenon of uncertainty as experienced by people living with relapsing-remitting multiple sclerosis.
by: Eva C van Reenen, et al.
Published: (2025-01-01)

Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis
by: Nasim Nehzat, et al.
Published: (2021-01-01)

Cost-Consequences of Cladribine Tablets for the Treatment of Highly Active Relapsing–Remitting Multiple Sclerosis in Italy
by: Barbara Polistena, et al.
Published: (2025-06-01)

Survey on first-line therapeutic management of relapsing–remitting multiple sclerosis in clinical practice in Spain
by: M. Llaneza, et al.
Published: (2025-01-01)

Evaluation of the Efficacy, Safety, and Adherence to Oral Drug Therapy in Patients with Relapsing–Remitting Multiple Sclerosis
by: Paulius Sėdžius, et al.
Published: (2025-04-01)

Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents
by: Alessandro Finkelsztejn, et al.
Published: (2012-10-01)

Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis.
by: Rezwan Ghassemi, et al.
Published: (2014-01-01)

Medication withdrawal may be an option for a select group of patients in relapsing-remitting multiple sclerosis
by: Guilherme Sciascia do Olival, et al.
Published: (2013-08-01)

Associations among IL-6 Signaling Molecules in Treg Populations in Patients with Relapsing-Remitting Multiple Sclerosis
by: Magdalena Kierasińska, et al.
Published: (2025-05-01)

Mental health outcomes in pregnant women with relapsing-remitting multiple sclerosis: a longitudinal cohort study
by: Lena Kristina Pfeffer, et al.
Published: (2025-07-01)

A Prospective Study on 25 Hydroxyvitamin D Serum Levels in Patients with Relapsing-Remitting Multiple Sclerosis
by: Georgi Slavov, et al.
Published: (2014-11-01)

Struggling for the dignity of women with Relapsing-Remitting Multiple Sclerosis: An interpretative phenomenological single case study analysis
by: Miertová, Michaela, et al.
Published: (2020-06-01)

Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis
by: Juan Ignacio Rojas, et al.
Published: (2012-08-01)

Experience with the long-term use of interferons β in the treatment of relapsing-remitting multiple sclerosis. Case report
by: Taras O. Simaniv, et al.
Published: (2024-12-01)